During the past decade, ISPL Wieslaw Jerzy Cubala conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "ISPL Wieslaw Jerzy Cubala" are "Neuropsychiatric Symptoms Related to Neurodegenerative Disease" (2 trials) and "Dementia-related Psychosis" (1 trials). Many other conditions were trialed in "ISPL Wieslaw Jerzy Cubala" in a lesser frequency.

Most popular intervention types in "ISPL Wieslaw Jerzy Cubala" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Pimavanserin" (2 trials), "Placebo" (2 trials), "Pimavanserin 20 mg" (1 trials) and "Pimavanserin 34 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "ISPL Wieslaw Jerzy Cubala" are 3 trials for "All" genders.

Currently, there are NaN active trials in "ISPL Wieslaw Jerzy Cubala". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in ISPL Wieslaw Jerzy Cubala, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ISPL Wieslaw Jerzy Cubala, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".